XML 56 R46.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Convertible Note Payable (Details)
3 Months Ended
Feb. 21, 2024
shares
Feb. 16, 2024
USD ($)
$ / shares
Feb. 05, 2024
shares
Feb. 01, 2024
USD ($)
$ / shares
Jan. 16, 2024
shares
Jan. 11, 2024
USD ($)
$ / shares
Jan. 01, 2024
USD ($)
$ / shares
Apr. 19, 2022
$ / shares
Nov. 19, 2021
$ / shares
Nov. 17, 2021
USD ($)
Mar. 31, 2024
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
Convertible Note Payable [line Items]                        
Debt extension fee (in Dollars)                   $ 65,639    
Note and accrued interest                   2.00%    
Debt redemptions weighted average price                     82.00%  
Interest accrues on note, description                     Interest accrues on the outstanding balance of the Note at 5% per annum compounded daily. Upon the occurrence of an Event of Default as defined in the Note, interest accrues at the lesser of 22% per annum or the maximum rate permitted by applicable law. In addition, upon any Event of Default, the Investor may accelerate the outstanding balance payable under the Note, which will increase automatically upon such acceleration by 15% or 5%, depending on the nature of the Event of Default.  
Redeem of outstanding note (in Dollars)                     $ 500,000  
Debt instrument redemption price percentage   82.00%   82.00%   82.00% 82.00%       82.00%  
Note redeemable into shares (in Shares) | shares                     1,655,965  
Weighted average price (in Dollars per share) | $ / shares                     $ 0.2959  
Debt redemption amount (in Dollars)   $ 150,000   $ 150,000   $ 150,000 $ 150,000          
Number of trading days   10 days   10 days   10 days 10 years          
Stock issued during period shares (in Shares) | shares 408,164   402,685   380,228              
Convertible Notes Payable [Member]                        
Convertible Note Payable [line Items]                        
Note converted into common stock               70,000 176,229   3,267  
Conversion price (in Dollars per share) | $ / shares   $ 0.3675   $ 0.3725   $ 0.3945 $ 0.3725   $ 29.79085   $ 150  
Interest expense (in Dollars)                     $ 14,312 $ 46,018
Convertible Notes Payable [Member] | China Pharma’s [Member]                        
Convertible Note Payable [line Items]                        
Note converted into common stock                     35,000  
Minimum [Member]                        
Convertible Note Payable [line Items]                        
Debt redemptions weighted average price                   85.00%    
Maximum [Member]                        
Convertible Note Payable [line Items]                        
Debt redemptions weighted average price                   82.00%    
Common Stock [Member] | China Pharma’s [Member]                        
Convertible Note Payable [line Items]                        
Conversion price (in Dollars per share) | $ / shares               $ 75